The Key Extended Entry Program (KEEP)

A methadone treatment program for opiate-dependent inmates

Vincent Tomasino, Arthur John Swanson, James Nolan, Harry I. Shuman

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The Key Extended Entry Program (KEEP) is the only known methadone treatment program for incarcerated opiate-dependent inmates in the United States. Initiated in 1987. KEEP performs approximately 18,000 detoxifications and 4,000 admissions for methadone treatment per year. Of those methadone treatment patients discharged to the community, mostly to outpatient KEEP programs, 74-80% report to their designated program. Recidivism rates reveal that 79% of KEEP patients were incarcerated again only once or twice during a recent 11-year period. Finally. KEEP data point to the importance of dedicating slots in the community for released inmates and maintaining them on sufficient blocking doses to eliminate the craving for heroin. About 6% of KEEP patients, some with mental illness, have a high incidence of recidivism.

Original languageEnglish (US)
Pages (from-to)14-20
Number of pages7
JournalMount Sinai Journal of Medicine
Volume68
Issue number1
StatePublished - Jan 2001

Fingerprint

Opiate Alkaloids
Methadone
Heroin
Outpatients
Therapeutics
Incidence

Keywords

  • Correctional treatment
  • Discharge planning
  • Jail
  • Methadone
  • Recidivism

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Key Extended Entry Program (KEEP) : A methadone treatment program for opiate-dependent inmates. / Tomasino, Vincent; Swanson, Arthur John; Nolan, James; Shuman, Harry I.

In: Mount Sinai Journal of Medicine, Vol. 68, No. 1, 01.2001, p. 14-20.

Research output: Contribution to journalArticle

@article{91eef86136c446b2bef37769bf6d0954,
title = "The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates",
abstract = "The Key Extended Entry Program (KEEP) is the only known methadone treatment program for incarcerated opiate-dependent inmates in the United States. Initiated in 1987. KEEP performs approximately 18,000 detoxifications and 4,000 admissions for methadone treatment per year. Of those methadone treatment patients discharged to the community, mostly to outpatient KEEP programs, 74-80{\%} report to their designated program. Recidivism rates reveal that 79{\%} of KEEP patients were incarcerated again only once or twice during a recent 11-year period. Finally. KEEP data point to the importance of dedicating slots in the community for released inmates and maintaining them on sufficient blocking doses to eliminate the craving for heroin. About 6{\%} of KEEP patients, some with mental illness, have a high incidence of recidivism.",
keywords = "Correctional treatment, Discharge planning, Jail, Methadone, Recidivism",
author = "Vincent Tomasino and Swanson, {Arthur John} and James Nolan and Shuman, {Harry I.}",
year = "2001",
month = "1",
language = "English (US)",
volume = "68",
pages = "14--20",
journal = "Annals of Global Health",
issn = "0027-2507",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The Key Extended Entry Program (KEEP)

T2 - A methadone treatment program for opiate-dependent inmates

AU - Tomasino, Vincent

AU - Swanson, Arthur John

AU - Nolan, James

AU - Shuman, Harry I.

PY - 2001/1

Y1 - 2001/1

N2 - The Key Extended Entry Program (KEEP) is the only known methadone treatment program for incarcerated opiate-dependent inmates in the United States. Initiated in 1987. KEEP performs approximately 18,000 detoxifications and 4,000 admissions for methadone treatment per year. Of those methadone treatment patients discharged to the community, mostly to outpatient KEEP programs, 74-80% report to their designated program. Recidivism rates reveal that 79% of KEEP patients were incarcerated again only once or twice during a recent 11-year period. Finally. KEEP data point to the importance of dedicating slots in the community for released inmates and maintaining them on sufficient blocking doses to eliminate the craving for heroin. About 6% of KEEP patients, some with mental illness, have a high incidence of recidivism.

AB - The Key Extended Entry Program (KEEP) is the only known methadone treatment program for incarcerated opiate-dependent inmates in the United States. Initiated in 1987. KEEP performs approximately 18,000 detoxifications and 4,000 admissions for methadone treatment per year. Of those methadone treatment patients discharged to the community, mostly to outpatient KEEP programs, 74-80% report to their designated program. Recidivism rates reveal that 79% of KEEP patients were incarcerated again only once or twice during a recent 11-year period. Finally. KEEP data point to the importance of dedicating slots in the community for released inmates and maintaining them on sufficient blocking doses to eliminate the craving for heroin. About 6% of KEEP patients, some with mental illness, have a high incidence of recidivism.

KW - Correctional treatment

KW - Discharge planning

KW - Jail

KW - Methadone

KW - Recidivism

UR - http://www.scopus.com/inward/record.url?scp=0035155692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035155692&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 14

EP - 20

JO - Annals of Global Health

JF - Annals of Global Health

SN - 0027-2507

IS - 1

ER -